Dr. Karin Hardiman is a colorectal surgeon and researcher at the University of Alabama at Birmingham.
The overarching goal of the Hardiman Lab’s research is to improve treatment and outcomes for patients with colorectal cancer. Her lab studies how tumor genetics are important in tumor progression and response to therapy.
As a colorectal surgeon, Dr. Hardiman has first-hand experience with the successes and toxicities of current treatment regimens for patients. In addition, Dr. Hardiman performs clinical and translational studies to try to improve outcomes for cancer survivors.
